Introduction Cardiovascular disease (CVD) remains a leading cause of morbidity and mortality globally. Traditional approaches to CVD management often rely on broad risk stratification and generalized treatment protocols. This “one-size-fits-all” approach, however, overlooks the significant heterogeneity in disease presentation and response to therapy across individuals. Says Dr. David Webb, the burgeoning fields of genomics and predictive […]